We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

118 hedge funds and large institutions have $91.5M invested in Sanofi Contingent Value Rights in 2014 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 34 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more capital invested

Capital invested by funds: $59.7M → $91.5M (+$31.8M)

7% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 14

0% more funds holding

Funds holding: 118 → 118 (0)

62% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 34

Holders
118
Holders Change
–
Holders Change %
0%
% of All Funds
3.15%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.08%
New
15
Increased
13
Reduced
34
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OAM
Oxford Asset Management
United Kingdom
+$2.4M
2
LCM
Lonestar Capital Management
California
+$888K
3
CPM
Chesapeake Partners Management
Maryland
+$332K
4
SAM
Silverback Asset Management
North Carolina
+$69.5K
5
CCA
Catalyst Capital Advisors
New York
+$46.6K

Top Sellers

Rank Fund Capital Flow
1
GCM
Gruss Capital Management
New York
-$3.02M
2
NM
Newtyn Management
New York
-$822K
3
BPGAM
BTG Pactual Global Asset Management
Bermuda
-$372K
4
MCM
Mason Capital Management
New York
-$278K
5
WA
Whitebox Advisors
Minnesota
-$250K
Name Holding Trade Value Shares
Change 		Change in
Stake
RNS
76
Robert N. Shapiro
$2K – – –
WT
77
Whittier Trust
California
$2K – – –
WTC
78
WhitTier Trust Company
Nevada
$2K – – –
Creative Planning
79
Creative Planning
Kansas
$2K +$618 +905 +56%
TWA
80
TCI Wealth Advisors
Arizona
$2K +$1.35K +1,974 +448%
WEC
81
Winslow Evans & Crocker
Massachusetts
$1.09K – – –
BPBT
82
Boston Private Bank & Trust
Massachusetts
$1K -$1.71K -2,500 -77%
ACS
83
Archford Capital Strategies
Illinois
$1K – – –
Fifth Third Bancorp
84
Fifth Third Bancorp
Ohio
$1K – – –
MCM
85
Manchester Capital Management
Vermont
$1K – – –
MWP
86
MYCIO Wealth Partners
Pennsylvania
$1K – – –
NES
87
New England Securities
New York
$1K – – –
Royal Bank of Canada
88
Royal Bank of Canada
Ontario, Canada
$1K – – –
OC
89
Oakworth Capital
Alabama
$1K +$683 +1,000 New
AIG
90
American International Group
New York
$531 -$437 -640 -49%
RC
91
RegentAtlantic Capital
New Jersey
$507 +$439 +642 New
CFA
92
CT Financial Advisors
Pennsylvania
$475 +$411 +602 New
ECM
93
Estabrook Capital Management
New York
$11 – – –
MPWT
94
MassMutual Private Wealth & Trust
Connecticut
$11 – – –
NM
95
Newtyn Management
New York
– -$822K -1,767,800 Closed
BPGAM
96
BTG Pactual Global Asset Management
Bermuda
– -$372K -799,183 Closed
ACP
97
Andalusian Capital Partners
Connecticut
– -$167K -358,575 Closed
Capstone Investment Advisors
98
Capstone Investment Advisors
New York
– -$139K -300,000 Closed
V
99
Veritable
Delaware
– -$25K -53,843 Closed
CCA
100
Castle Creek Arbitrage
Colorado
– -$19K -41,549 Closed
1 2 3
4
5

GCVRZ Hedge Fund Activity: Q4 2014 in Review

118 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q4 2014, worth a combined $91.5M — up 53% from $59.7M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new GCVRZ positions and 14 closed out — a net gain of 1 holder — while 13 added to existing stakes and 34 trimmed.

The largest buyer was Oxford Asset Management, opening a new position worth an estimated $2.4M. The largest seller was Gruss Capital Management, cutting an estimated $3.02M.

  • 118 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q4 2014, unchanged from Q3 2014.
  • Funds reported $91.5M of Sanofi Contingent Value Rights stock for Q4 2014, up 53% quarter-over-quarter.
  • 15 funds opened new Sanofi Contingent Value Rights positions in Q4 2014 and 14 closed out, a net change of +1 holder.
  • The largest Sanofi Contingent Value Rights buyer in Q4 2014 was Oxford Asset Management, an estimated $2.4M added.
  • The largest Sanofi Contingent Value Rights seller in Q4 2014 was Gruss Capital Management, an estimated $3.02M sold.

Based on aggregated 13F filings for Q4 2014.